Baby's liver size may reveal hidden impact of gestational diabetes
NCT ID NCT07312838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will use ultrasound to measure the length and volume of the liver in babies of mothers with gestational diabetes. Researchers want to see if these measurements can serve as early markers of how the mother's blood sugar levels affect the baby. The study will compare 115 pregnant women with and without gestational diabetes, but no treatment or intervention is given.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a new way to check how gestational diabetes is affecting the baby during pregnancy.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not find a clear link, and results may not change current care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FETAL LİVER VOLUME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Placental clues: do progesterone receptors influence gestational diabetes?
- New study aims to uncover hidden challenges of pregnancy in somaliland
- Nurse coaching may tame gestational diabetes risks
- New study aims to stop diabetes before it starts in moms with gestational diabetes
- Massive study aims to tame pregnancy diabetes risks
- Could a tiny port replace daily insulin shots for pregnant women?